Cite
HARVARD Citation
Chihara, D. et al. (2017). Dose adjusted‐EPOCH‐R and mediastinal disease may improve outcomes for patients with gray‐zone lymphoma. British journal of haematology. pp. 503-506. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chihara, D. et al. (2017). Dose adjusted‐EPOCH‐R and mediastinal disease may improve outcomes for patients with gray‐zone lymphoma. British journal of haematology. pp. 503-506. [Online].